Chang C C, Chang T Y
Biochemistry. 1986 Apr 8;25(7):1700-6. doi: 10.1021/bi00355a039.
We reported in another paper [Chang, C. C. Y., Doolittle, G. M., & Chang, T. Y. (1986) Biochemistry (preceding paper in this issue)] that in Chinese hamster ovary (CHO) cells activation of acyl coenzyme A:cholesterol acyltransferase (ACAT) activity by treating cells with cycloheximide was abolished by providing exogenous sterol in the medium. We now report that providing 20 mM DL-mevalonate to cells grown in sterol-free medium increases the ACAT activity by approximately 6-fold and diminishes the cycloheximide activation effect. The mevalonate supplement has no significant effect on the rate of triglyceride or polar lipid synthesis, [3H]cholesterol efflux, or bulk protein degradation in cells. The activation of ACAT by mevalonate is prevented by adding a specific squalene oxide cyclase inhibitor to cells, indicating the requirement for endogenous sterol synthesis to mediate the mevalonate effect. In sterol-free medium, if sterol synthesis is blocked by specific enzyme inhibitors or through mutation, the ACAT activation by cycloheximide is again abolished. These results support the hypothesis that there may exist a short-lived factor(s) serving directly or indirectly as an endogenous ACAT inhibitor(s), the inhibitory action of this (these) factor(s) is (are) abolished, and its (their) turnover rate(s) is (are) increased by either exogenous sterol or by sterol endogenously synthesized. Conversely, removing exogenous sterol coupled with blocking endogenous sterol synthesis decreases the turnover rate(s) of the inhibitor(s), rendering its (their) action insensitive to intracellular degradation over the time period studied.
我们在另一篇论文中报道过[张,C.C.Y.,杜利特尔,G.M.,& 张,T.Y.(1986年)《生物化学》(本期之前的论文)],在中国仓鼠卵巢(CHO)细胞中,用放线菌酮处理细胞激活酰基辅酶A:胆固醇酰基转移酶(ACAT)活性的作用,会因在培养基中提供外源性固醇而被消除。我们现在报道,向在无固醇培养基中生长的细胞提供20 mM DL-甲羟戊酸,可使ACAT活性增加约6倍,并减弱放线菌酮的激活作用。甲羟戊酸补充剂对细胞中甘油三酯或极性脂质合成速率、[3H]胆固醇流出或总蛋白降解没有显著影响。向细胞中添加特异性氧化角鲨烯环化酶抑制剂可阻止甲羟戊酸对ACAT的激活,这表明需要内源性固醇合成来介导甲羟戊酸的作用。在无固醇培养基中,如果固醇合成被特异性酶抑制剂阻断或通过突变阻断,放线菌酮对ACAT的激活作用会再次被消除。这些结果支持这样一种假说,即可能存在一种短寿命因子直接或间接作为内源性ACAT抑制剂,该(这些)因子的抑制作用被消除,并且其(它们的)周转率会因外源性固醇或内源性合成的固醇而增加。相反,去除外源性固醇并阻断内源性固醇合成会降低抑制剂的周转率,使其(它们)的作用在所研究的时间段内对细胞内降解不敏感。